JP2014098049A5 - - Google Patents

Download PDF

Info

Publication number
JP2014098049A5
JP2014098049A5 JP2014040226A JP2014040226A JP2014098049A5 JP 2014098049 A5 JP2014098049 A5 JP 2014098049A5 JP 2014040226 A JP2014040226 A JP 2014040226A JP 2014040226 A JP2014040226 A JP 2014040226A JP 2014098049 A5 JP2014098049 A5 JP 2014098049A5
Authority
JP
Japan
Prior art keywords
peaks
furan
acetyl
dione
diffraction pattern
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2014040226A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014098049A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2014098049A publication Critical patent/JP2014098049A/ja
Publication of JP2014098049A5 publication Critical patent/JP2014098049A5/ja
Withdrawn legal-status Critical Current

Links

JP2014040226A 2010-03-19 2014-03-03 がん幹細胞を標的とするための新規の化合物および組成物 Withdrawn JP2014098049A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US31589010P 2010-03-19 2010-03-19
US31588610P 2010-03-19 2010-03-19
US61/315,890 2010-03-19
US61/315,886 2010-03-19
US32581410P 2010-04-19 2010-04-19
US61/325,814 2010-04-19

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2013500246A Division JP5602935B2 (ja) 2010-03-19 2011-03-21 がん幹細胞を標的とするための新規の化合物および組成物

Publications (2)

Publication Number Publication Date
JP2014098049A JP2014098049A (ja) 2014-05-29
JP2014098049A5 true JP2014098049A5 (enExample) 2014-11-27

Family

ID=50940329

Family Applications (11)

Application Number Title Priority Date Filing Date
JP2014040227A Withdrawn JP2014098050A (ja) 2010-03-19 2014-03-03 がん幹細胞を標的とするための新規の化合物および組成物
JP2014040226A Withdrawn JP2014098049A (ja) 2010-03-19 2014-03-03 がん幹細胞を標的とするための新規の化合物および組成物
JP2014040225A Expired - Fee Related JP5993390B2 (ja) 2010-03-19 2014-03-03 がん幹細胞を標的とするための新規の化合物および組成物
JP2015035285A Pending JP2015098489A (ja) 2010-03-19 2015-02-25 がん幹細胞を標的とするための新規の化合物および組成物
JP2015179115A Expired - Fee Related JP6246169B2 (ja) 2010-03-19 2015-09-11 がん幹細胞を標的とするための新規の方法
JP2016194176A Withdrawn JP2016222723A (ja) 2010-03-19 2016-09-30 がん幹細胞を標的とするための新規の化合物および組成物
JP2017199380A Withdrawn JP2018002744A (ja) 2010-03-19 2017-10-13 がん幹細胞を標的とするための新規の方法
JP2018081329A Withdrawn JP2018115209A (ja) 2010-03-19 2018-04-20 がん幹細胞を標的とするための新規の化合物および組成物
JP2020014705A Withdrawn JP2020063308A (ja) 2010-03-19 2020-01-31 がん幹細胞を標的とするための新規の化合物および組成物
JP2020082479A Pending JP2020114888A (ja) 2010-03-19 2020-05-08 がん幹細胞を標的とするための新規の方法
JP2021197732A Pending JP2022020002A (ja) 2010-03-19 2021-12-06 がん幹細胞を標的とするための新規の化合物および組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2014040227A Withdrawn JP2014098050A (ja) 2010-03-19 2014-03-03 がん幹細胞を標的とするための新規の化合物および組成物

Family Applications After (9)

Application Number Title Priority Date Filing Date
JP2014040225A Expired - Fee Related JP5993390B2 (ja) 2010-03-19 2014-03-03 がん幹細胞を標的とするための新規の化合物および組成物
JP2015035285A Pending JP2015098489A (ja) 2010-03-19 2015-02-25 がん幹細胞を標的とするための新規の化合物および組成物
JP2015179115A Expired - Fee Related JP6246169B2 (ja) 2010-03-19 2015-09-11 がん幹細胞を標的とするための新規の方法
JP2016194176A Withdrawn JP2016222723A (ja) 2010-03-19 2016-09-30 がん幹細胞を標的とするための新規の化合物および組成物
JP2017199380A Withdrawn JP2018002744A (ja) 2010-03-19 2017-10-13 がん幹細胞を標的とするための新規の方法
JP2018081329A Withdrawn JP2018115209A (ja) 2010-03-19 2018-04-20 がん幹細胞を標的とするための新規の化合物および組成物
JP2020014705A Withdrawn JP2020063308A (ja) 2010-03-19 2020-01-31 がん幹細胞を標的とするための新規の化合物および組成物
JP2020082479A Pending JP2020114888A (ja) 2010-03-19 2020-05-08 がん幹細胞を標的とするための新規の方法
JP2021197732A Pending JP2022020002A (ja) 2010-03-19 2021-12-06 がん幹細胞を標的とするための新規の化合物および組成物

Country Status (11)

Country Link
EP (2) EP3108750B1 (enExample)
JP (11) JP2014098050A (enExample)
CN (3) CN104016951B (enExample)
CA (3) CA2959951A1 (enExample)
DK (1) DK3108750T3 (enExample)
ES (1) ES2689928T3 (enExample)
HU (1) HUE066482T2 (enExample)
NZ (2) NZ712826A (enExample)
PT (1) PT2547205T (enExample)
RU (2) RU2015142279A (enExample)
SG (3) SG10201706265PA (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20160430T1 (hr) 2007-09-10 2016-05-20 Boston Biomedical, Inc. Nova grupa inhibitora stat3 puta i inhibitora puta matičnih stanica karcinoma
US9730909B2 (en) * 2010-03-19 2017-08-15 Boston Biomedical, Inc Methods for targeting cancer stem cells
CA2959951A1 (en) * 2010-03-19 2011-09-22 Boston Biomedical, Inc. Naphthofuran compounds and compositions for targeting cancer stem cells
KR20150139955A (ko) 2013-04-09 2015-12-14 보스톤 바이오메디칼, 인크. 암 치료에 사용하기 위한 2-아세틸나프토[2,3-b]푸란-4,9-디온
BR112017026025A2 (pt) * 2015-06-03 2018-08-14 Boston Biomedical Inc composições que compreendem um inibidor de stemness de câncer e um agente imunoterápico para uso no tratamento de câncer
GB201515391D0 (en) * 2015-08-28 2015-10-14 Amazentis Sa Compositions
GB201515387D0 (en) * 2015-08-28 2015-10-14 Amazentis Sa Compositions
JP6751658B2 (ja) 2016-11-15 2020-09-09 クラリオン株式会社 音声認識装置、音声認識システム
US11299469B2 (en) 2016-11-29 2022-04-12 Sumitomo Dainippon Pharma Oncology, Inc. Naphthofuran derivatives, preparation, and methods of use thereof
US10646464B2 (en) 2017-05-17 2020-05-12 Boston Biomedical, Inc. Methods for treating cancer

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61205257A (ja) * 1985-03-08 1986-09-11 Ishihara Sangyo Kaisha Ltd ベンゾイルウレア系化合物、その製法及びそれを含有する抗ガン剤
EP0945131A1 (de) * 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Perorale Wirkstoff-Suspension
JP2003525862A (ja) * 1999-01-27 2003-09-02 ザ ユニヴァーシティー オブ サウス フロリダ ヒト癌の治療のためのstat3シグナル伝達の阻害
AU2003275056A1 (en) * 2002-09-17 2004-04-08 Arqule, Inc. Novel lapacho compounds and methods of use thereof
AR042052A1 (es) * 2002-11-15 2005-06-08 Vertex Pharma Diaminotriazoles utiles como inhibidores de proteinquinasas
EP1849830B1 (en) * 2005-01-28 2012-02-29 Takeda Pharmaceutical Company Limited Finely divided composition containing poorly water soluble substance
JP2006290871A (ja) * 2005-03-16 2006-10-26 Taheebo Japan Kk 抗癌性を示す化合物およびその中間体ならびにそれらの製造方法
PE20070546A1 (es) * 2005-09-30 2007-07-04 Smithkline Beecham Corp Composiciones farmaceuticas de talnetant
EP1860126A1 (en) * 2006-05-26 2007-11-28 INEOS Manufacturing Belgium NV Polyolefin powder
HRP20160430T1 (hr) 2007-09-10 2016-05-20 Boston Biomedical, Inc. Nova grupa inhibitora stat3 puta i inhibitora puta matičnih stanica karcinoma
KR20110031370A (ko) * 2008-07-08 2011-03-25 베타 파마, 인크. 염산 icotinib, 합성, 결정형, 약학적 조성물 및 이의 사용
US9730909B2 (en) * 2010-03-19 2017-08-15 Boston Biomedical, Inc Methods for targeting cancer stem cells
CA2793526C (en) * 2010-03-19 2018-05-01 Boston Biomedical, Inc. Naphthofuran compounds and compositions for targeting cancer stem cells
CA2959951A1 (en) * 2010-03-19 2011-09-22 Boston Biomedical, Inc. Naphthofuran compounds and compositions for targeting cancer stem cells

Similar Documents

Publication Publication Date Title
JP2014098049A5 (enExample)
MX2024001891A (es) Preparacion de psilocibina, diferentes formas polimorficas, intermediarios, formulaciones, y su uso.
JP2015042636A5 (ja) 有機化合物
JP2014512451A5 (enExample)
JP2016028085A5 (enExample)
WO2017123763A8 (en) Processes for the preparation of 2,5-furandicarboxylic acid and intermediates and derivatives thereof
JP2015044837A5 (enExample)
JP2015010091A5 (enExample)
JP2016530199A5 (enExample)
JP2009138000A5 (enExample)
WO2015108599A3 (en) Method for preparation of a superalloy having a crystallographic texture controlled microstructure by electron beam melting
WO2013121235A3 (en) Process for preparation of dronedarone by removal of hydroxyl group
WO2017137142A8 (en) A polymer, composition, forming sacrificial layer and method for semiconductor device therewith
JP2015516425A5 (enExample)
JP2009179634A5 (enExample)
JP2014521585A5 (enExample)
WO2014006637A3 (en) Improved process for preparing benzofuran-2-carboxamide derivatives
JP2013255887A5 (enExample)
JP2017535510A5 (enExample)
JP2013503145A5 (enExample)
JP2011529942A5 (enExample)
JP2017533926A5 (enExample)
JP2018502165A5 (enExample)
WO2016008570A8 (de) Verfahren zur herstellung einer flächenelektrode
JP2012017322A5 (enExample)